Prostate News Archive
11-Feb-2009
Miraculins Announces Improved Detection of Aggressive Prostate Cancer With Combination of PSP94 and Free Over Total ... (Marketwire via Yahoo! Finance)
Miraculins Inc., a medical diagnostic company focused on developing and commercializing diagnostic tests for unmet clinical needs, is pleased to announce results which demonstrate that PSP94 in urine can be used to improve the performance of free over total PSA ratio in detecting aggressive prostate cancer. New Treatment Hope For Prostate Cancer (Science Daily)
Scientists have developed a potential new treatment for patients with prostate cancer. They have produced a monoclonal antibody to a unique tumor marker for the treatment of prostate cancer. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of ... (Lancet)
Intermediate or surrogate endpoints for survival can shorten time lines for drug approval. We aimed to assess circulating tumour cell (CTC) count as a prognostic factor for survival in patients with progressive, metastatic, castration-resistant prostate cancer receiving first-line chemotherapy. ST. CLAIR: Prostate screening helps (Suburban Journals)
Getting men to visit a health clinic to get their prostate gland tested can often be a challenge, said Erline Pooler, a registered nurse with the St. Clair County Health Department.
Back to Prostate News Archive
